EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment

Xiaoling Shang, Chenyue Zhang, Yuanyuan Lv, Xiaoxiao Zhang, Kaiyue Guo, Huijuan Li, Haiyong Wang iD

ImmunoTargets and Therapy · 2024-10 · Volume 13 · 571-583

DOI: 10.2147/itt.s483093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2024-10. Verfasst von Xiaoling Shang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Cancer Hospital and Institute, Shandong University, Jinan, 250117, People's Republic of China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ICI rechallengeextensive stage small cell lung cancermetastatic sitessurvivaltumor microenvironment

Autor:innen und Institutionen

  • Shandong Cancer Hospital and Institute, Shandong University, Jinan, 250117, People's Republic of China.
  • Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai, People's Republic of China.
  • Department of Clinical Drug Research, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, People's Republic of China.
  • Department of Radiation Oncology, Qilu Hospital of Shandong University, Shandong University, Jinan, 250117, People's Republic of China.
  • Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, People's Republic of China.

ORCID-Profile: Haiyong Wang

Zitieren

APA

Shang, X., Zhang, C., Lv, Y., Zhang, X., Guo, K., Li, H., & Wang, H. (2024). Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment. ImmunoTargets and Therapy, Volume 13, 571-583. https://doi.org/10.2147/itt.s483093

Vancouver

Shang X, Zhang C, Lv Y, Zhang X, Guo K, Li H, et al. Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment. ImmunoTargets and Therapy. 2024;Volume 13:571-583. doi:10.2147/itt.s483093

BibTeX
@article{Shang2024,
  author = {Shang, Xiaoling and Zhang, Chenyue and Lv, Yuanyuan and Zhang, Xiaoxiao and Guo, Kaiyue and Li, Huijuan and Wang, Haiyong},
  title = {Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment},
  journal = {ImmunoTargets and Therapy},
  year = {2024},
  volume = {Volume 13},
  pages = {571--583},
  doi = {10.2147/itt.s483093}
}
Kostenlos starten →